Table 3.
2020 | 2019 | |
---|---|---|
High-grade glioma | ||
Biopsy | 19 (37.25%) | 16 (39%) |
STR | 17 (33.3%) | 15 (36.6%) |
NTR | 7 (13.76%) | 2 (4.9%) |
GTR | 8 (15.69%) | 8 (19.5%) |
Meningioma | ||
Sim 1 | 2 (15.4%) | 1 (5%) |
Sim 2 | 9 (69.2%) | 10 (50%) |
Sim 3 | 1 (7.7%) | 3 (15%) |
Sim 4 | 1 (7.7%) | 5 (25%) |
TSS (STR) | – | 1 (5%) |
Others | ||
Biopsy | 14 (19.2%) | 10 (13.7%) |
STR | 8 (11%) | 28 (38.4%) |
NTR | 12 (16.4%) | 3 (4.1%) |
GTR | 39 (53.4%) | 32 (43.8%) |
GTR gross total resection, NTR near total resection, STR subtotal resection, Sim Simpson’s grade, TSS transsphenoidal surgery